1
S Y O K S Y O K
P A D A A N A K P A D A A N A K
Dr.N.L.KD. DEWI SANGAWATI,SpADr.N.L.KD. DEWI SANGAWATI,SpA
SMF ANAK RSUD MATARAMSMF ANAK RSUD MATARAM
2
DEFINISI SYOKDEFINISI SYOK
SINDROM KLINIS AKIBAT KEGAGALAN SISTEM SINDROM KLINIS AKIBAT KEGAGALAN SISTEM
SIRKULASI UNTUK MENCUKUPI :SIRKULASI UNTUK MENCUKUPI :
NUTRISINUTRISI PASOKANPASOKAN METABOLISMEMETABOLISME OKSIGENOKSIGEN UTILISASIUTILISASI JARINGAN TUBUHJARINGAN TUBUH
FASE: FASE: KOMPENSASIKOMPENSASI
DEKOMPENSASIDEKOMPENSASIIREVERSIBELIREVERSIBEL DEFISIENSI O2 DEFISIENSI O2
SELULERSELULER
3
Etiologi SyokEtiologi Syok
TypeType Primary InsultPrimary Insult Common CausesCommon CausesHypovolemicHypovolemic Decreased circulatingDecreased circulating Dehydration, hemorrhage,Dehydration, hemorrhage,
blood volblood vol capilarry leakscapilarry leaksDistributiveDistributive Vasodilation -> venousVasodilation -> venous Sepsis, anaphylaxis,Sepsis, anaphylaxis,
pooling -> decreased preloadpooling -> decreased preload drug intoxication,drug intoxication,spinal cord injuryspinal cord injury
ObstructiveObstructive Obstruction of cardiacObstruction of cardiac Cardiac tamponade, tensionCardiac tamponade, tensionfilling/out flowfilling/out flow pneumothoracx, pulmonary pneumothoracx, pulmonary
embolusembolusCardiogenicCardiogenic Decreased contractilityDecreased contractility Congenital heart disease,Congenital heart disease,
myocarditis, dysritmiamyocarditis, dysritmiaDissociativeDissociative O2 not released fromO2 not released from CO poisoning,CO poisoning,
hemoglobinhemoglobin methemoglobinemiamethemoglobinemia
4
FUNGSI SISTEM SIRKULASIFUNGSI SISTEM SIRKULASI JANTUNGJANTUNG CURAH JANTUNGCURAH JANTUNG METABOLISMEMETABOLISME PEMB. DARAHPEMB. DARAH ALIRAN DARAHALIRAN DARAH ADEKUATADEKUAT JARINGANJARINGAN VOL. DARAHVOL. DARAH O2 DELIVERYO2 DELIVERY
METABOLITMETABOLIT
ELIMINASIELIMINASI
DI ORGAN DI ORGAN PEMBUANGANPEMBUANGAN
5
Pengaturan curah jantung dan tekanan darahPengaturan curah jantung dan tekanan darah
PreloadPreload ContractilityContractilityAfterloadAfterload
Heart rateHeart rate Stroke volumeStroke volume
Cardiac outputCardiac output Systemic vascular resistanceSystemic vascular resistance
Blood pressureBlood pressure
6
ShockShock
HypotensionHypotension
PreloadPreload
Cellular Cellular hypoxiahypoxia
Intravasculer volumeIntravasculer volume Myocardial contractility Myocardial contractility
Anaerobic metabolismAnaerobic metabolism
Membrane permeabilityMembrane permeability
Metabolic by-products:Metabolic by-products:
- lactic acid- lactic acid
- myocardial depressant factor- myocardial depressant factor
- endogeneous catecholamines- endogeneous catecholamines
- adenine nucleotides- adenine nucleotides
7
STADIUM SYOKSTADIUM SYOK
KOMPENSASIKOMPENSASI
DEKOMPENSASIDEKOMPENSASI
IREVERSIBEL (PRETERMINAL)IREVERSIBEL (PRETERMINAL)
PERJALANAN KLINIS PERJALANAN KLINIS BERSIFAT PROGRESIFBERSIFAT PROGRESIF
8
FASE I: KOMPENSASIFASE I: KOMPENSASI
KOMPENSASI TEMPORERKOMPENSASI TEMPORER
SIMPATIS, SIMPATIS, SVR, SVR, TEKANAN NADI TEKANAN NADI
DISTRIBUSI SELEKTIF ALIRAN DARAHDISTRIBUSI SELEKTIF ALIRAN DARAH
RETENSI NA & AIRRETENSI NA & AIR
KLINIS : KLINIS : * TAKHIKARDIA* TAKHIKARDIA* GADUH GELISAH* GADUH GELISAH
* KULIT PUCAT DINGIN * KULIT PUCAT DINGIN
* PENGISIAN KAPILER >> * PENGISIAN KAPILER >>
9
FASE 2: DEKOMPENSASIFASE 2: DEKOMPENSASI KOMPENSASI MULAI GAGALKOMPENSASI MULAI GAGAL HIPOPERFUSI HIPOPERFUSI HIPOKSIA JAR. HIPOKSIA JAR. METAB. ANAEROBIK METAB. ANAEROBIK
GGN. METAB. SELULER GGN. METAB. SELULER PELEPASAN MEDIATOR : PELEPASAN MEDIATOR : * VASODILATASI* VASODILATASI
* PERMEABILITAS * PERMEABILITAS * DEPRESI MIOKARD * DEPRESI MIOKARD * GGN KOAGULASI * GGN KOAGULASI
KLINIS : KLINIS : TAKHIKARDIA TAKHIKARDIA TEKANAN DARAH TEKANAN DARAH TAKIPNU TAKIPNU PERFUSI PERIFER PERFUSI PERIFER
ASIDOSIS (+)ASIDOSIS (+) OLIGURI (+) OLIGURI (+) TINGKAT KESADARAN TINGKAT KESADARAN
10
FASE 3: IREVERSIBELFASE 3: IREVERSIBEL KOMPENSASI GAGALKOMPENSASI GAGAL CADANGAN ENERGI TUBUH CADANGAN ENERGI TUBUH KERUSAKAN/KEMATIAN SELKERUSAKAN/KEMATIAN SEL DISFUNGSI ORGAN DISFUNGSI ORGAN
MULTIPELMULTIPEL KLINIS : KLINIS : * T.D TAK TERUKUR* T.D TAK TERUKUR * NADI TAK TERABA* NADI TAK TERABA
* TINGKAT KESADARAN* TINGKAT KESADARAN * ANURIA (+)* ANURIA (+)* GAGAL MULTI ORGAN * GAGAL MULTI ORGAN DAN KEMATIAN DAN KEMATIAN
11
Manifestasi Klinis SyokManifestasi Klinis Syok
Clinical SignsClinical Signs CompensatedCompensated UncompensatedUncompensated IrreversibleIrreversible
Blood loss (%)Blood loss (%) Up to 25Up to 25 25 - 4025 - 40 > 40> 40
Heart rate Heart rate Tachycardia + Tachycardia + Tachycardia ++ Tachycardia ++ Tachy/bradycardiaTachy/bradycardia
Systolic BPSystolic BP NN N or falling N or falling PlummetingPlummeting
Pulse volumePulse volume N/ N/ + + ++ ++
Capillary refill Capillary refill N/ N/ + + ++ ++
SkinSkin Cool, pale Cool, pale Cold, mottled Cold, mottled Cold, deathly paleCold, deathly pale
Respiratory rateRespiratory rate Tachypnoea + Tachypnoea + Tachypnoea ++Tachypnoea ++ Sighing rsp.Sighing rsp.
Mental stateMental state Mild agitationMild agitation Lethargic Lethargic Reacts only to painReacts only to pain
UncooperativeUncooperative or unresponsiveor unresponsive
12
GANGGUAN PERFUSI PERIFERGANGGUAN PERFUSI PERIFER CORE > PERIFER TEMP. ~ > 2CORE > PERIFER TEMP. ~ > 2O O CC CAPILLARY REFILL >> : CAPILLARY REFILL >> :
* NAIL BED PRESS* NAIL BED PRESS * BLANCHING SKIN TEST* BLANCHING SKIN TEST
PRODUKSI URIN PRODUKSI URIN (N) (N) BAYI BAYI = 2 ml/kg/jam= 2 ml/kg/jam
ANAKANAK = 1 ml/kg/jam= 1 ml/kg/jam
13
TATALAKSANA RESUSITASI TATALAKSANA RESUSITASI SYOKSYOK
RESUSITASI AWALRESUSITASI AWAL OKSIGEN 100% + VENTILATORY SUPPORTOKSIGEN 100% + VENTILATORY SUPPORT PASANG AKSES VASKULER (90 DETIK)PASANG AKSES VASKULER (90 DETIK) FLUID CHALLENGE (20 ml/kg BB)FLUID CHALLENGE (20 ml/kg BB)
SECEPATNYA < 10 MENITSECEPATNYA < 10 MENIT DPT DIULANGI 2-3 KALIDPT DIULANGI 2-3 KALI KRISTALOID/KOLOIDKRISTALOID/KOLOID
PEMANTAUAN AWALPEMANTAUAN AWAL RESPON THD FLUID CHALLENGERESPON THD FLUID CHALLENGE PANTAU PROD. URIN (KATETER)PANTAU PROD. URIN (KATETER) STAT. LAB/PENUNJANGSTAT. LAB/PENUNJANG
14
MonitoringMonitoring State of consiousness-Glasgow Coma ScaleState of consiousness-Glasgow Coma Scale Respiratory rate and characterRespiratory rate and character Cardiovascular parametersCardiovascular parameters
Skin and core temperature differenceSkin and core temperature difference Pulse rate and volumePulse rate and volume Blood pressureBlood pressure Capillary perfusion timeCapillary perfusion time Central venous pressure - should be monitored in a Central venous pressure - should be monitored in a
patient where there has been poor response to fluid patient where there has been poor response to fluid therapy or with established shock. therapy or with established shock.
Urinary output - urine bag, or preferably catheter; Urinary output - urine bag, or preferably catheter; output should be 1-2 ml/kg body weightoutput should be 1-2 ml/kg body weight
Pulse oximetryPulse oximetry
15
RESUSITASI LANJUTRESUSITASI LANJUT
BILA FLUID CHALLENGE NON BILA FLUID CHALLENGE NON RESPONSIVERESPONSIVE
INTUBASI & VENT. MEKANIKINTUBASI & VENT. MEKANIK PASANG CVP & LOADING HATI-HATIPASANG CVP & LOADING HATI-HATI KOREKSI EFEK INOTROPIK NEGATIFKOREKSI EFEK INOTROPIK NEGATIF
Hb < 5 g/dl Hb < 5 g/dl PRC 10 ml/kg BB (Ht 40-50 vol %) PRC 10 ml/kg BB (Ht 40-50 vol %)
OBAT INOTROPIKOBAT INOTROPIK
16
PEMANTAUAN LANJUTPEMANTAUAN LANJUT CARI PENYEBAB SYOK (CXR, KONSULTASI)CARI PENYEBAB SYOK (CXR, KONSULTASI) EVALUASI FUNGSI SIST. ORGAN LAIN : EVALUASI FUNGSI SIST. ORGAN LAIN :
ATN/PRE RENAL FAILUREATN/PRE RENAL FAILURE ARDSARDS CARDIAC FUNCTIONCARDIAC FUNCTION GGN. KOAGULASI/DICGGN. KOAGULASI/DIC ORGAN-ORGAN LAINORGAN-ORGAN LAIN
17
CHILD IN SHOCKCHILD IN SHOCK
(1) (1) OXYGEN OXYGEN (2) CRYSTALLOID(2) CRYSTALLOID 20 ml/kg)20 ml/kg)
IMPROVEMENTIMPROVEMENT
NO IMPROVEMENTNO IMPROVEMENT
NO IMPROVEMENTNO IMPROVEMENT (3) CRYSTALLOID (3) CRYSTALLOID - INCREASE MABP - INCREASE MABP (20 ml/kg)(20 ml/kg) - NORMALIZATION HR- NORMALIZATION HR
- IMPROVED PERFUSION- IMPROVED PERFUSION - URINE OUTPUT > 1 ml/kg/hr- URINE OUTPUT > 1 ml/kg/hr
URINARY CATHETERURINARY CATHETER
ESTABLISH CVPESTABLISH CVP ESTABLISH ETIOLOGYESTABLISH ETIOLOGY,,OOBSERVATIONBSERVATION
CVP < 5 TorrCVP < 5 Torr CVP > 5 Torr CVP > 5 Torr CRYSTALLOID INFUSIONCRYSTALLOID INFUSION NO IMPROVEMENT NO IMPROVEMENT UNTIL CVP - 5 TorrUNTIL CVP - 5 Torr IMPROVEMENTIMPROVEMENT ABG, HT, NaK, GLUC Ca, ABG, HT, NaK, GLUC Ca,
SWAN GANZ CATHETERSWAN GANZ CATHETER ESTABLISH ETIOLOGYESTABLISH ETIOLOGY CO, RAP, PAP, POAPCO, RAP, PAP, POAPCONFIRM SOURCECONFIRM SOURCE OF FLUID LOSSOF FLUID LOSS
CENTRAL VENOUS PRESSUREST
ROKE
VO
LUM
E
1. CORRECT ACIDOSIS
2. Co. GLUCOSE
3. INTROPIC SUPPORT
18
Stadium syok septik dan manifestasi klinisStadium syok septik dan manifestasi klinis
StadiumStadium Tanda KlinisTanda Klinis Gang fisiologisGang fisiologis BiokimiawiBiokimiawi
Warm ShockWarm Shock perfusi perifer (N) perfusi perifer (N) Smv O Smv O22 hipokarbiahipokarbia(Hiperdinamik)(Hiperdinamik) kulit hangat keringkulit hangat kering VO VO22 hipoxiahipoxia
HR HR nadi bounding nadi bounding CO CO kadar laktat kadar laktat suhu / (tak stabil) suhu / (tak stabil) SVR SVR hiperglikemiahiperglikemiaRR RR , gg. kesadaran, gg. kesadaran
Cold ShockCold Shock sianosis sianosis CO CO hipoxiahipoxia(Hipodinamik)(Hipodinamik) kulit dingin lembabkulit dingin lembab SVR SVR asidosis metabasidosis metab
nadi kecil, lemah nadi kecil, lemah CVP CVP koagulopatikoagulopatiHR HR , Oliguria, Oliguria Smv O Smv O22 hipoglikemihipoglikemishallow breathing shallow breathing pe pe kesadaran kesadaran
MOSFMOSF bergantung sistem bergantung sistem KomaKoma sesuai sesuai yang terkenayang terkena ARDS, CHF, RFARDS, CHF, RF jenisjenis
GI bleeding/DIC GI bleeding/DIC organ failureorgan failure
19
TATALAKSANA SYOK SEPTIKTATALAKSANA SYOK SEPTIK AB BROAD SPECTRUMAB BROAD SPECTRUM SESUAI KULTUR SESUAI KULTUR RESUSITASI CAIRAN : KOLOID/KRISTALOIDRESUSITASI CAIRAN : KOLOID/KRISTALOID OBAT INOTROPIK : OBAT INOTROPIK : DOBUTAMIN + DOPAMINDOBUTAMIN + DOPAMIN
ISOPRENALIN/ADRENALINISOPRENALIN/ADRENALIN
SVR SVR VASODILATASI PERIFER VASODILATASI PERIFER KOREKSI : KOREKSI : - HIPO/HIPERGLIKEMI - HIPO/HIPERGLIKEMI
- ASAM BASA- ASAM BASA- ELEKTROLIT- ELEKTROLIT
20
TATALAKSANA SYOK TATALAKSANA SYOK ANAFILAKTIKANAFILAKTIK
STOP ALERGEN PENYEBAB + ADRENALIN (IM)STOP ALERGEN PENYEBAB + ADRENALIN (IM) AIR WAY & RESPIRATION ADEKUATAIR WAY & RESPIRATION ADEKUAT
WHEEZINGWHEEZING NEBULASI ADRENALIN/SALBUTAMOL NEBULASI ADRENALIN/SALBUTAMOL OBSTRUKSIOBSTRUKSI INTUBASI/SURGICAL AIRWAY INTUBASI/SURGICAL AIRWAY
SIRKULASI & HEMODINAMIKSIRKULASI & HEMODINAMIK VASOPRESOR VASOPRESOR : ADRENALIN (10 : ADRENALIN (10 g/kg BB)g/kg BB) FLUID LOADING FLUID LOADING : KRISTALOID (20 ml/kg BB/IV-IO): KRISTALOID (20 ml/kg BB/IV-IO)
RE ASSESSMENT ABC RESUSITASIRE ASSESSMENT ABC RESUSITASI WHEEZING (+)WHEEZING (+) NEBULASI SALBUTAMOL NEBULASI SALBUTAMOL
BILA PERLU BILA PERLU (+) HIDROKORTISON (IV)(+) HIDROKORTISON (IV) (+) (+)
AMINOPILIN/SALBUTAMOL DRIPAMINOPILIN/SALBUTAMOL DRIP SYOK BERLANJUT : SYOK BERLANJUT : KOLOID + INOTROPIKKOLOID + INOTROPIK
21
TATALAKSANA SYOK TATALAKSANA SYOK KARDIOGENIKKARDIOGENIK
OKSIGENASI ADEKUATOKSIGENASI ADEKUAT KOREKSI GGN ASAM BASA & ELEKTROLITKOREKSI GGN ASAM BASA & ELEKTROLIT KURANGI RASA SAKIT & ANSIETAS KURANGI RASA SAKIT & ANSIETAS ATASI DISRITMIA JANTUNGATASI DISRITMIA JANTUNG KELEBIHAN PRELOADKELEBIHAN PRELOAD : : DIURETIKADIURETIKA
KONTRAKTILITAS:KONTRAKTILITAS: FLUID CHALLENGE SESUAI CVP/POAPFLUID CHALLENGE SESUAI CVP/POAP OBAT OBAT
INOTROPIK (+)INOTROPIK (+)
BEBAN AFTERLOAD (SVR BEBAN AFTERLOAD (SVR ) : ) : VASODILATORVASODILATOR
KOREKSI PENYEBAB PRIMERKOREKSI PENYEBAB PRIMER
22
Key points in managementKey points in management Remember BP and pulse are unreliable indicators Remember BP and pulse are unreliable indicators
in early septic shockin early septic shock Look for minor degrees of mental impairment Look for minor degrees of mental impairment
(anxiety, restlessness)(anxiety, restlessness) Do not delay treatment, try to prevent the onset of Do not delay treatment, try to prevent the onset of
hypotension, metabolic acidosis, and hypoxiahypotension, metabolic acidosis, and hypoxia Give adequate fluids early in treatment, especially Give adequate fluids early in treatment, especially
colloidscolloids Do not use inotropic agents until the patient has Do not use inotropic agents until the patient has
received adequate fluid therapyreceived adequate fluid therapy Monitor blood glucose, gases, and pH, and treat Monitor blood glucose, gases, and pH, and treat
appropriatelyappropriately
Top Related